Cao, Hengyi
Chen, Oliver Y.
McEwen, Sarah C.
Forsyth, Jennifer K.
Gee, Dylan G.
Bearden, Carrie E.
Addington, Jean
Goodyear, Bradley
Cadenhead, Kristin S.
Mirzakhanian, Heline
Cornblatt, Barbara A.
CarriĆ³n, Ricardo E.
Mathalon, Daniel H.
McGlashan, Thomas H.
Perkins, Diana O.
Belger, Aysenil
Thermenos, Heidi
Tsuang, Ming T.
van Erp, Theo G.M.
Walker, Elaine F.
Hamann, Stephan
Anticevic, Alan
Woods, Scott W.
Cannon, Tyrone D.
Funding for this research was provided by:
Brain and Behavior Research Foundation (27068)
National Institute of Mental Health (U01 MH081902)
National Institute of Mental Health (P50 MH066286)
National Institute of Mental Health (U01 MH081857)
National Institute of Mental Health (U01 MH82022)
National Institute of Mental Health (U01 MH066134)
National Institute of Mental Health (U01 MH081944)
National Institute of Mental Health (U01 MH066069)
National Institute of Mental Health (R01 MH076989)
National Institute of Mental Health (U01 MH081988)
Article History
First Online: 2 May 2020
Compliance with ethical standards
:
: Dr. Cannon has served as a consultant for Boehringer-Ingelheim Pharmaceuticals and Lundbeck A/S. The other authors report no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.